• ONO Pharmaceutical relocated its corporate venture capital unit, Ono Venture Investment, to Cambridge, Massachusetts from South San Francisco.
• The move places the team inside ONO PHARMA USA’s office, tightening access to the Greater Boston life sciences cluster.
• Strategy targets deeper engagement with portfolio companies, where a growing share is based in the Boston area.
• OVI aims to accelerate open innovation, focusing on biotechnology investments in North America.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ONO Pharmaceutical Co. Ltd. published the original content used to generate this news brief on October 01, 2026, and is solely responsible for the information contained therein.